• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1 edition.国际头痛学会基于临床的头痛登记处指南,第 1 版。
Cephalalgia. 2022 Oct;42(11-12):1099-1115. doi: 10.1177/03331024221099035. Epub 2022 May 6.
2
The American Registry for Migraine Research: Research Methods and Baseline Data for an Initial Patient Cohort.美国偏头痛研究注册处:初始患者队列的研究方法和基线数据。
Headache. 2020 Feb;60(2):337-347. doi: 10.1111/head.13688. Epub 2019 Nov 22.
3
[Headache registry in Szeged: Experiences regarding to migraine patients].塞格德头痛登记:偏头痛患者的相关经验
Ideggyogy Sz. 2023 May 30;76(5-6):205-211. doi: 10.18071/isz.76.0205.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Recurrent headache in chinese children: any agreement between clinician diagnosis and symptom-based diagnoses using the International Classification of Headache Disorders (Second Edition)?中国儿童复发性头痛:临床医生诊断与使用《国际头痛疾病分类(第二版)》基于症状的诊断之间是否存在一致性?
J Child Neurol. 2006 Feb;21(2):132-8. doi: 10.1177/08830738060210020101.
6
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
7
Characteristics of the first 2,000 patients registered in a specialist headache clinic.一家专科头痛诊所登记的首批2000名患者的特征。
Neurologia. 2015 May;30(4):208-13. doi: 10.1016/j.nrl.2013.12.010. Epub 2014 Jan 30.
8
Classification and clinical features of headache disorders in Pakistan: a retrospective review of clinical data.巴基斯坦头痛疾病的分类与临床特征:临床数据的回顾性分析
PLoS One. 2009 Jun 8;4(6):e5827. doi: 10.1371/journal.pone.0005827.
9
Short-term diagnostic stability of probable headache disorders based on the International Classification of Headache Disorders, 3rd edition beta version, in first-visit patients: a multicenter follow-up study.基于《国际头痛疾病分类》第3版beta版,初诊患者中可能的头痛疾病的短期诊断稳定性:一项多中心随访研究
J Headache Pain. 2016;17:13. doi: 10.1186/s10194-016-0605-1. Epub 2016 Feb 19.
10
Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker.改善偏头痛管理中的医学沟通:开发数字偏头痛追踪器的改良德尔菲研究。
Headache. 2018 Oct;58(9):1358-1372. doi: 10.1111/head.13426.

引用本文的文献

1
The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders.世界卫生组织部门间全球行动计划:癫痫和其他神经系统疾病以及头痛革命:从头痛负担到头痛疾病全球行动计划。
J Headache Pain. 2024 Jan 4;25(1):4. doi: 10.1186/s10194-023-01700-3.
2
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry.从 Galca-Only 登记研究中 1 年随访的 1055 例患者的真实世界证据:排除在临床试验之外的偏头痛患者使用加奈珠单抗的长期疗效和耐受性。
J Headache Pain. 2023 Nov 22;24(1):157. doi: 10.1186/s10194-023-01690-2.
3
Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030.重新思考头痛作为一个全球公共卫生案例模型,以实现 2030 年可持续发展目标 3 的健康目标。
J Headache Pain. 2023 Oct 27;24(1):140. doi: 10.1186/s10194-023-01666-2.
4
Methodological considerations on real-world evidence studies of monoclonal antibodies against the CGRP-pathway for migraine: a systematic review.关于偏头痛 CGRP 通路单克隆抗体的真实世界证据研究的方法学考虑:系统评价。
J Headache Pain. 2023 Jun 22;24(1):75. doi: 10.1186/s10194-023-01611-3.

本文引用的文献

1
Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study.美国偏头痛的诊断、咨询、治疗和影响:OVERCOME(美国)研究的结果。
Headache. 2022 Feb;62(2):122-140. doi: 10.1111/head.14259. Epub 2022 Jan 25.
2
Development and validation of a novel patient-reported outcome measure in people with episodic migraine and chronic migraine: The Activity Impairment in Migraine Diary.开发和验证一种用于偶发性偏头痛和慢性偏头痛患者的新型患者报告结局测量工具:偏头痛活动障碍日记。
Headache. 2022 Jan;62(1):89-105. doi: 10.1111/head.14229. Epub 2021 Dec 28.
3
Atogepant for the Preventive Treatment of Migraine.阿替利珠单抗用于偏头痛的预防性治疗。
N Engl J Med. 2021 Aug 19;385(8):695-706. doi: 10.1056/NEJMoa2035908.
4
E-diary use in clinical headache practice: A prospective observational study.电子日记在临床头痛实践中的应用:一项前瞻性观察研究。
Cephalalgia. 2021 Oct;41(11-12):1161-1171. doi: 10.1177/03331024211010306. Epub 2021 May 2.
5
Child Neurology Telemedicine: Understanding the Data We Have and Finding the Patients We Do Not See.儿童神经科远程医疗:了解我们所拥有的数据并找到我们未曾见过的患者。
Pediatr Neurol. 2021 Mar;116:84. doi: 10.1016/j.pediatrneurol.2020.11.010. Epub 2020 Dec 13.
6
Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults.国际头痛协会成人发作性偏头痛预防性治疗偏头痛发作的对照试验指南。
Cephalalgia. 2020 Sep;40(10):1026-1044. doi: 10.1177/0333102420941839. Epub 2020 Jul 28.
7
The Reconstructed Cohort Design: A Method to Study Rare Neurodegenerative Diseases in Population-Based Settings.重建队列设计:一种在基于人群的环境中研究罕见神经退行性疾病的方法。
Neuroepidemiology. 2020;54(2):114-122. doi: 10.1159/000502863. Epub 2020 Jan 7.
8
Registry stakeholders.登记处利益相关者。
EFORT Open Rev. 2019 Jun 3;4(6):330-336. doi: 10.1302/2058-5241.4.180077. eCollection 2019 Jun.
9
Validation of a photophobia symptom impact scale.畏光症状影响量表的验证。
Cephalalgia. 2019 Oct;39(11):1445-1454. doi: 10.1177/0333102419845641. Epub 2019 May 22.
10
The diagnostic accuracy of headache measurement instruments: A systematic review and meta-analysis focusing on headaches associated with musculoskeletal symptoms.头痛测量仪器的诊断准确性:一项系统评价和荟萃分析,重点关注与肌肉骨骼症状相关的头痛。
Cephalalgia. 2019 Sep;39(10):1313-1332. doi: 10.1177/0333102419840777. Epub 2019 Apr 18.

国际头痛学会基于临床的头痛登记处指南,第 1 版。

Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1 edition.

机构信息

Department of Neurology, Mayo Clinic, Phoenix, Arizona, USA.

Headache Science & Neurorehabilitation Unit, National Neurological Institute C. Mondino Foundation, Pavia, Italy.

出版信息

Cephalalgia. 2022 Oct;42(11-12):1099-1115. doi: 10.1177/03331024221099035. Epub 2022 May 6.

DOI:10.1177/03331024221099035
PMID:35514209
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10141527/
Abstract

Clinic-based headache registries collect data for a wide variety of purposes including delineating disease characteristics, longitudinal natural disease courses, headache management approaches, quality of care, treatment safety and effectiveness, factors that predict treatment response, health care resource utilization, clinician adherence to guidelines, and cost-effectiveness. Registry data are valuable for numerous stakeholders, including individuals with headache disorders and their caregivers, healthcare providers, scientists, healthcare systems, regulatory authorities, pharmaceutical companies, employers, and policymakers. This International Headache Society document may serve as guidance for developing clinic-based headache registries. Use of registry data requires a formal research protocol that includes: 1) research aims; 2) methods for data collection, harmonization, analysis, privacy, and protection; 3) methods for human subject protection; and 4) publication and dissemination plans. Depending upon their objectives, headache registries should include validated headache-specific questionnaires, patient reported outcome measures, data elements that are used consistently across studies (i.e., "common data elements"), and medical record data. Amongst other data types, registries may be linked to healthcare and pharmacy claims data, biospecimens, and neuroimaging data. Headache diagnoses should be made according to the International Classification of Headache Disorders diagnostic criteria. The data from well-designed headache registries can provide wide-ranging and novel insights into the characteristics, burden, and treatment of headache disorders and ultimately lead to improvements in the management of patients with headache.

摘要

基于诊所的头痛登记处收集的数据用于各种目的,包括描绘疾病特征、纵向自然疾病过程、头痛管理方法、护理质量、治疗安全性和有效性、预测治疗反应的因素、卫生保健资源利用、临床医生对指南的遵守情况以及成本效益。登记处数据对许多利益相关者都有价值,包括头痛障碍患者及其护理人员、医疗保健提供者、科学家、医疗保健系统、监管机构、制药公司、雇主和政策制定者。这份国际头痛协会文件可作为开发基于诊所的头痛登记处的指南。使用登记处数据需要一个正式的研究方案,其中包括:1)研究目的;2)数据收集、协调、分析、隐私和保护方法;3)保护人类受试者的方法;4)出版和传播计划。根据其目标,头痛登记处应包括经过验证的头痛特异性问卷、患者报告的结果测量、在研究中一致使用的数据元素(即“通用数据元素”)和病历数据。除其他数据类型外,登记处可能与医疗保健和药房索赔数据、生物样本和神经影像学数据相关联。头痛诊断应根据国际头痛疾病分类标准进行。精心设计的头痛登记处的数据可以提供广泛而新颖的见解,了解头痛障碍的特征、负担和治疗,最终改善头痛患者的管理。